脑卒中后认知障碍危险因素分析及列线图预测模型构建与验证

    Analysis of risk factors for cognitive impairment after stroke and construction and validation of its nomogram prediction model

    • 摘要:
      目的: 分析脑卒中后认知障碍(PSCI)的危险因素,构建列线图预测模型并对其应用效果进行验证。
      方法: 选取首次急性缺血性脑卒中病人356例,其中建模组211例,验证组145例。卒中后3个月通过采用蒙特利尔认知评估量表评估建模组病人认知功能障碍情况,分析PSCI影响因素,构建PSCI风险预测列线图模型,采用ROC曲线和Hosmer-Lemeshow拟合优度检验评价模型的区分度和校准度,绘制预测模型的临床决策曲线。
      结果: 病人年龄、教育程度、职业、入院NIHSS评分、颅内动脉狭窄和基线社会支持评定量表评分均为PSCI的独立影响因素(P < 0.05 ~ P < 0.01)。基于独立危险因素构建PSCI列线图预测模型,模型一致性指数为0.826。ROC曲线显示,该模型预测建模组病人PSCI的AUC为0.842,灵敏度为80.5%,特异度为73.0%;预测验证组PSCI的AUC为0.839,灵敏度为86.5%,特异度为68.4%。临床决策曲线显示,该预测模型具有临床应用价值。
      结论: PSCI风险预测模型预测效能良好,有利于临床及早识别PSCI高危人群。

       

      Abstract:
      Objective To analyze the risk factors of post-stroke cognitive impairment (PSCI), construct the prediction model of nomogram, and verify its application effects.
      Methods A total of 356 patients with the first acute ischemic stroke were selected, including 211 cases in the modeling group and 145 cases in the verification group. After 3 months of stroke, the cognitive impairment of patients in the modeling group was assessed by using the Montreal Cognitive Assessment Scale, the influencing factors of PSCI were analyzed, the PSCI risk prediction histogram model was constructed. The differentiation and calibration degree of the model were evaluated by ROC curve and Hosmer-Lemeshow goodness of fit test, and the clinical decision curve of the prediction model was drawn.
      Results The age, education level, occupation, NIHSS score on admission, intracranial artery stenosis and baseline social support rating scale score were the independent factors of PSCI (P < 0.05 to P < 0.01). The PSCI nomogram prediction model was constructed based on independent risk factors, and the model consistency index was 0.826. ROC curve showed that the AUC of PSCI predicted by the model was 0.842, the sensitivity was 80.5%, and the specificity was 73.0%. The AUC of PSCI in the verification group was 0.839, the sensitivity was 86.5%, and the specificity was 68.4%. The clinical decision curve showed that the prediction model had clinical application value.
      Conclusions The PSCI risk prediction model has good predictive efficacy, which is conducive to early clinical identification of PSCI high-risk groups.

       

    /

    返回文章
    返回